Integration	O
of	O
interferon	O
-	O
alpha	O
/	O
beta	O
signalling	O
to	O
p53	O
responses	O
in	O
tumour	B-Cancer
suppression	O
and	O
antiviral	O
defence	O
.	O

Swift	O
elimination	O
of	O
undesirable	O
cells	B-Cell
is	O
an	O
important	O
feature	O
in	O
tumour	B-Cancer
suppression	O
and	O
immunity	O
.	O

The	O
tumour	B-Cancer
suppressor	O
p53	O
and	O
interferon	O
-	O
alpha	O
and	O
-	O
beta	O
(	O
IFN	O
-	O
alpha	O
/	O
beta	O
)	O
are	O
essential	O
for	O
the	O
induction	O
of	O
apoptosis	O
in	O
cancerous	B-Cell
cells	I-Cell
and	O
in	O
antiviral	O
immune	O
responses	O
,	O
respectively	O
,	O
but	O
little	O
is	O
known	O
about	O
their	O
interrelationship	O
.	O

Here	O
we	O
show	O
that	O
transcription	O
of	O
the	O
p53	O
gene	O
is	O
induced	O
by	O
IFN	O
-	O
alpha	O
/	O
beta	O
,	O
accompanied	O
by	O
an	O
increase	O
in	O
p53	O
protein	O
level	O
.	O

IFN	O
-	O
alpha	O
/	O
beta	O
signalling	O
itself	O
does	O
not	O
activate	O
p53	O
;	O
rather	O
,	O
it	O
contributes	O
to	O
boosting	O
p53	O
responses	O
to	O
stress	O
signals	O
.	O

We	O
show	O
examples	O
in	O
which	O
p53	O
gene	O
induction	O
by	O
IFN	O
-	O
alpha	O
/	O
beta	O
contributes	O
to	O
tumour	B-Cancer
suppression	O
.	O

Furthermore	O
,	O
we	O
show	O
that	O
p53	O
is	O
activated	O
in	O
virally	O
infected	O
cells	B-Cell
to	O
evoke	O
an	O
apoptotic	O
response	O
and	O
that	O
p53	O
is	O
critical	O
for	O
antiviral	O
defence	O
of	O
the	O
host	O
.	O

Our	O
study	O
reveals	O
a	O
hitherto	O
unrecognized	O
link	O
between	O
p53	O
and	O
IFN	O
-	O
alpha	O
/	O
beta	O
in	O
tumour	B-Cancer
suppression	O
and	O
antiviral	O
immunity	O
,	O
which	O
may	O
have	O
therapeutic	O
implications	O
.	O

